Castel San Pietro, Switzerland’s Medacta's first half contains two familiar irritants for a global orthopedic company: currency translation and the cost of expanding the business.
Company News Premium
Medacta: Growth in the Operating Room, Headwinds in Translation
1 min read Premium comments

Medacta2Q26 earnings2Q26 sales2Q26 revenue
Author
React:
